← All stocks

GeneDx Holdings Corp.

WGS Net buying
CIK 0001818331 #1896 in the set updated 21 Sep 2026
Bought (12 mo)
$106.60M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$23.92M
$1.90M on a plan · $13.07M straight out of an exercise
Sold at will
$8.94M
26 of 123 sales
Net
+$82.68M
+$97.66M against sales at will

By person

12 insiders · 157 transactions
15.9×

Katherine Stueland holds 15.9 times base salary in stock. $11.43M of shares against $715.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Katherine Stueland last reported holding, valued at $99.00, the price Class A Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Meister Keith A.
Director
$74.03M (29)
+$74.03M
4,808,275
16.12%
$476.00M
+93.8%
Casdin Capital, LLC entity
Director
$32.57M (5)
+$32.57M
3,707,164
12.43%
$366.99M
+5.7%
Stueland Katherine
CHIEF EXECUTIVE OFFICER
$12.90M (47) scheduled
−$12.90M
115,476
0.3872%
$11.43M
+11.3%
RUCH JOSHUA
Director
$6.09M (15)
−$6.09M
153,382
0.5143%
$15.18M
−7.6%
Feeley Kevin
CHIEF FINANCIAL OFFICER
$4.07M (49) scheduled
−$4.07M
44,945
0.1507%
$4.45M
−49.8%
Dechairo Bryan
Chief Operating Officer
$850.56K (12) scheduled
−$850.56K
0
0.0000%
$0.00
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
10% owner
2,719,692
9.12%
$269.24M
−27.1%
Ryan Jason
Director
118,764
0.3982%
$11.76M
−64.0%
PFENNIGER RICHARD C JR
Director
45,082
0.1512%
$4.46M
+63.0%
Leproust Emily M.
Director
24,852
0.0833%
$2.46M
+197.6%
Casdin Eli
Director
24,093
0.0808%
$2.39M
+217.3%
Fuchs Thomas
Director
1,146
0.0038%
$113.45K
Insider
Date
Role
Action
Shares
Price
Amount
Stueland Katherine
4 Mar 2026
CHIEF EXECUTIVE OFFICER
Sell
9,133
$79.25
$723.78K
Stueland Katherine
4 Mar 2026
CHIEF EXECUTIVE OFFICER
Sell
10,465
$78.61
$822.62K
Stueland Katherine
4 Mar 2026
CHIEF EXECUTIVE OFFICER
Sell
5,861
$77.63
$454.97K
Feeley Kevin
4 Mar 2026
CHIEF FINANCIAL OFFICER
Sell
2,220
$79.25
$175.93K
Feeley Kevin
4 Mar 2026
CHIEF FINANCIAL OFFICER
Sell
2,543
$78.61
$199.90K
Feeley Kevin
4 Mar 2026
CHIEF FINANCIAL OFFICER
Sell
1,424
$77.63
$110.54K
Feeley Kevin
2 Mar 2026
CHIEF FINANCIAL OFFICER
Sell
287
$77.52
$22.25K
Dechairo Bryan
2 Feb 2026
Chief Operating Officer
Sell
1,166
$100.31
$116.97K
Dechairo Bryan
2 Feb 2026
Chief Operating Officer
Sell
1,662
$99.40
$165.20K
Dechairo Bryan
2 Feb 2026
Chief Operating Officer
Sell
492
$98.61
$48.52K
Dechairo Bryan
2 Feb 2026
Chief Operating Officer
Sell
93
$96.77
$9.00K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
728
$162.04
$117.96K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
11,234
$161.16
$1.81M
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
8,944
$160.45
$1.44M
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
6,279
$159.28
$1.00M
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
2,016
$158.40
$319.34K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
147
$162.04
$23.82K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
2,268
$161.16
$365.50K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
1,805
$160.45
$289.61K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
1,268
$159.28
$201.96K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
407
$158.40
$64.47K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
72
$162.04
$11.67K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
1,117
$161.16
$180.01K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
889
$160.45
$142.64K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
625
$159.28
$99.55K
RUCH JOSHUA
24 Nov 2025
Director
Sell indirect
201
$158.40
$31.84K

What was left out

Form 4 filings counted 53
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 81
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 370,118
History held since 26 Jul 2021